SCHEMBL862219

SCHEMBL862219

CCCCCCCCC1CCC[C@@H]1CCCCCCC(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.69
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
KMT2A Q03164 2/20 0.61
ALOX15 P16050 2/20 0.61
HSD17B10 Q99714 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
PDE4A P27815 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10580840 1.00 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL9513062 1.00 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL126631 1.00 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL5545406 1.00 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL21941814 1.00 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL11739322 0.98 ALOX5 (0.67) ALOX5GPR84PPARGPPARDPPARA
Hydrogen Sulfide SCHEMBL27802019 0.98 ALOX5 (0.67) ALOX5GPR84PPARGPPARDPPARA
Charcoal, Activated SCHEMBL5436853 0.98 ALOX5 (0.67) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL11239681 0.96 ALOX5 (0.64) ALOX5GPR84PPARGPPARDPPARA
SCHEMBL9623339 0.96 ALOX5 (0.69) ALOX5GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11534404-B2 Multilayer beads for pharmaceutical use SUCAMPO AG (CH) 2022-12-27 US disclosed
US-20200390708-A1 MULTILAYER BEADS FOR PHARMACEUTICAL USE GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT 2020-12-17 US disclosed
US-20170042908-A1 METHOD FOR TREATING GEOGRAPHIC ATROPHY ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) 2017-02-16 US disclosed
US-20170042908-A1 METHOD FOR TREATING GEOGRAPHIC ATROPHY ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY (JP) 2017-02-16 US disclosed
US-20170020890-A1 PHARMACEUTICAL COMPOSITION COMPRISING FATTY ACID DERIVATIVE SUCAMPO AG (CH) 2017-01-26 US disclosed
US-20170020890-A1 PHARMACEUTICAL COMPOSITION COMPRISING FATTY ACID DERIVATIVE SUCAMPO AG (CH) 2017-01-26 US disclosed
US-20160120840-A1 METHOD AND COMPOSITION FOR TREATING NONEROSIVE REFLUX DISEASE SUCAMPO AG (CH) 2016-05-05 US disclosed
US-9242950-B2 Method for preparing a fatty acid derivative R-TECH UENO, LTD. (JP) 2016-01-26 US disclosed
US-20150272961-A1 METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION SUCAMPO AG (CH) 2015-10-01 US disclosed
US-20150272961-A1 METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION SUCAMPO AG (CH) 2015-10-01 US disclosed
US-20090298928-A1 COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT R-TECH UENO, LTD. 2009-12-03 US disclosed
US-20090209643-A1 METHOD FOR MODULATING STEM CELL GROWTH SUCAMPO AG (CH) 2009-08-20 US disclosed
US-20090062381-A1 AQUEOUS COMPOSITION SUCAMPO AG (CH) 2009-03-05 US disclosed
US-20080207759-A1 Prevent damage in mammals by administering prostaglandins SUCAMPO AG (CH) 2008-08-28 US disclosed
US-7355064-B2 Method for preparing 15-keto-prostaglandin E derivative R-TECH UENO, LTD. (JP) 2008-04-08 US disclosed
US-20080070979-A1 METHOD FOR PROMOTING GASTROINTESTINAL BICARBONATE SECRETION SUCAMPO AG (CH) 2008-03-20 US disclosed
US-20080033036-A1 Composition and Method for Promoting Hair Growth R-TECH UENO, LTD. (JP) 2008-02-07 US disclosed
US-20070298134-A1 Composition and Method for Scalp and Hair Treatment R-TECH UENO, LTD. (JP) 2007-12-27 US disclosed
US-20070185206-A1 Method for preparing 15-keto-prostaglandin E derivative R-TECH UENO, LTD. (JP) 2007-08-09 US disclosed
US-7253295-B2 Chloride channel opener SUCAMPO AG (CH) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209643-A1 METHOD FOR MODULATING STEM CELL GROWTH PGF, PTGS1, MKI67 ALOX5 101/4885GPR84 657/4885PPARG 186/4885
US-20070298134-A1 Composition and Method for Scalp and Hair Treatment PTGER3, PTGDR2, HSD3B2 ALOX5 14/4885GPR84 2047/4885PPARG 133/4885
US-20170020890-A1 PHARMACEUTICAL COMPOSITION COMPRISING FATTY ACID DERIVATIVE SCD, FASN, SCD5 ALOX5 24/4885GPR84 543/4885PPARG 11/4885
US-20150272961-A1 METHOD FOR TREATING MUCOSITIS, METHOD FOR TREATING TUMOR, AND PHARMACEUTICAL COMBINATION FABP2, FABP6, SI ALOX5 4/4885GPR84 2177/4885PPARG 34/4885
US-20090298928-A1 COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT PTGER3, PTGDR2, HSD3B2 ALOX5 14/4885GPR84 2047/4885PPARG 133/4885
US-20090062381-A1 AQUEOUS COMPOSITION PTGES, PTGER1, ALOX15 ALOX5 13/4885GPR84 502/4885PPARG 273/4885
US-20080033036-A1 Composition and Method for Promoting Hair Growth COX15, PGF, PTGS2 ALOX5 17/4885GPR84 1594/4885PPARG 147/4885
US-20070185206-A1 Method for preparing 15-keto-prostaglandin E derivative PTGES, PTGES2, HPGD ALOX5 5/4885GPR84 3557/4885PPARG 229/4885
US-20080070979-A1 METHOD FOR PROMOTING GASTROINTESTINAL BICARBONATE SECRETION SI, SLC10A2, VIP ALOX5 896/4885GPR84 1018/4885PPARG 1515/4885
US-20200390708-A1 MULTILAYER BEADS FOR PHARMACEUTICAL USE PGA5, PTGER1, PTGER3 ALOX5 44/4885GPR84 3019/4885PPARG 159/4885
US-20170042908-A1 METHOD FOR TREATING GEOGRAPHIC ATROPHY ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION HPGD, HSD17B12, HSD17B7 ALOX5 44/4885GPR84 3479/4885PPARG 65/4885
US-20080207759-A1 Prevent damage in mammals by administering prostaglandins TXNRD2, TXN2, PRDX5 ALOX5 215/4885GPR84 3406/4885PPARG 244/4885
US-11534404-B2 Multilayer beads for pharmaceutical use PGA5, PTGER1, PTGER3 ALOX5 44/4885GPR84 3019/4885PPARG 159/4885
US-20160120840-A1 METHOD AND COMPOSITION FOR TREATING NONEROSIVE REFLUX DISEASE FABP2, FABP6, SLC10A2 ALOX5 4/4885GPR84 1126/4885PPARG 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.